The correlation between the methylation levels of SCNN1B and the clinicopathological parameters of the CRC patients, such as age, sex, tumour differentiation, tumour stage, lymph node metastasis, tumour localization, RAS mutation, BRAF mutation, and MSI status, was evaluated. Here, SCNN1B is linked to neoplasm.